Literature DB >> 14686914

Glutamate signaling in peripheral tissues.

Eiichi Hinoi1, Takeshi Takarada, Taichi Ueshima, Yuriko Tsuchihashi, Yukio Yoneda.   

Abstract

The hypothesis that l-glutamate (Glu) is an excitatory amino acid neurotransmitter in the mammalian central nervous system is now gaining more support after the successful cloning of a number of genes coding for the signaling machinery required for this neurocrine at synapses in the brain. These include Glu receptors (signal detection), Glu transporters (signal termination) and vesicular Glu transporters (signal output through exocytotic release). Relatively little attention has been paid to the functional expression of these molecules required for Glu signaling in peripheral neuronal and non-neuronal tissues; however, recent molecular biological analyses show a novel function for Glu as an extracellular signal mediator in the autocrine and/or paracrine system. Emerging evidence suggests that Glu could play a dual role in mechanisms underlying the maintenance of cellular homeostasis - as an excitatory neurotransmitter in the central neurocrine system and an extracellular signal mediator in peripheral autocrine and/or paracrine tissues. In this review, the possible Glu signaling methods are outlined in specific peripheral tissues including bone, testis, pancreas, and the adrenal, pituitary and pineal glands.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14686914     DOI: 10.1046/j.1432-1033.2003.03907.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  64 in total

Review 1.  Intercellular glutamate signaling in the nervous system and beyond.

Authors:  David E Featherstone
Journal:  ACS Chem Neurosci       Date:  2009-10-09       Impact factor: 4.418

2.  NMDA receptors are expressed in lymphocytes activated both in vitro and in vivo.

Authors:  Anna P Mashkina; Dasha Cizkova; Ivo Vanicky; Alexander A Boldyrev
Journal:  Cell Mol Neurobiol       Date:  2010-04-23       Impact factor: 5.046

Review 3.  GCPII imaging and cancer.

Authors:  C A Foss; R C Mease; S Y Cho; H J Kim; M G Pomper
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 4.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

Review 5.  Glutamate receptors as seen by light: spectroscopic studies of structure-function relationships.

Authors:  K A Mankiewicz; V Jayaraman
Journal:  Braz J Med Biol Res       Date:  2007-11       Impact factor: 2.590

6.  Vagotomy upregulates expression of the N-methyl-D-aspartate receptor NR2D subunit in the stomach.

Authors:  Kanako Watanabe; Takeshi Kanno; Tadayuki Oshima; Hiroto Miwa; Chikara Tashiro; Tomoyuki Nishizaki
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

Review 7.  The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.

Authors:  Yonatan Ganor; Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2014-03-02       Impact factor: 3.575

8.  High Ethanol and Acetaldehyde Inhibit Glutamatergic Transmission in the Hippocampus of Aldh2-Knockout and C57BL/6N Mice: an In Vivo and Ex Vivo Analysis.

Authors:  Mostofa Jamal; Asuka Ito; Naoko Tanaka; Takanori Miki; Kiyoshi Ameno; Hiroshi Kinoshita
Journal:  Neurotox Res       Date:  2020-02-15       Impact factor: 3.911

9.  Poly(γ-Glutamic Acid) as an Exogenous Promoter of Chondrogenic Differentiation of Human Mesenchymal Stem/Stromal Cells.

Authors:  Joana C Antunes; Roman Tsaryk; Raquel M Gonçalves; Catarina Leite Pereira; Constantin Landes; Christoph Brochhausen; Shahram Ghanaati; Mário A Barbosa; C James Kirkpatrick
Journal:  Tissue Eng Part A       Date:  2015-04-30       Impact factor: 3.845

10.  Breast cancer expresses functional NMDA receptors.

Authors:  William G North; Guohong Gao; Vincent A Memoli; Roy H Pang; Launa Lynch
Journal:  Breast Cancer Res Treat       Date:  2009-09-26       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.